Metformin and vitamin K, as PKM2 inhibitors, have shown inhibitory effects on glycolysis, cell proliferation, and drug resistance in various cancers such as osteosarcoma (94), non-small cell lung cancer (95), and hepatocellular carcinoma (96). The gene discussed is PKM; the disease is cancer.